The Team Behind the Platform Built at the intersection of nucleoside chemistry, clinical drug development, and public-company execution. 60+ Combined Years in Drug Development Multiple FDA Drug Approvals NASDAQ IPO Experience Moderna mRNA Chemistry Inventor Daniel Jones Co-Founder and CEO Experienced public company CEO and director. Inventor of EPINUC and Direct RNA Sequencing Atanu Roy, PhD Co-Founder and CSO 30+ years of experience in modified nucleoside, DNA, and RNA chemistry. Inventor of Moderna’s mRNA chemistry platform. Joel Eisner, PhD Scientific Advisor Former SVP, GeneCentric Therapeutics. Oncology Pharmacology Louis St.L. ODea, MD Strategic Advisor Former CMO, Moderna. Multiple FDA Drug Approvals x